Back to Search
Start Over
Immune globulin subcutaneous, human – klhw 20% for primary humoral immunodeficiency: an open-label, Phase III study.
- Source :
- Immunotherapy (1750743X); Sep2019, Vol. 11 Issue 16, p1371-1386, 16p
- Publication Year :
- 2019
Details
- Language :
- English
- ISSN :
- 1750743X
- Volume :
- 11
- Issue :
- 16
- Database :
- Complementary Index
- Journal :
- Immunotherapy (1750743X)
- Publication Type :
- Academic Journal
- Accession number :
- 139369081
- Full Text :
- https://doi.org/10.2217/imt-2019-0159